Cargando…
Does everybody with mildly elevated HsTnT without ECG changes have a high risk of cardiovascular events and mortality?
Autores principales: | Sattar, Yasar, Almas, Talal, Majmundar, Monil, Ullah, Waqas, Alraies, M. Chadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319512/ https://www.ncbi.nlm.nih.gov/pubmed/34345650 http://dx.doi.org/10.1016/j.ijcha.2021.100838 |
Ejemplares similares
-
Partial vena cava occlusion (VCO) to counteract refractory heart failure: A new era in interventional heart failure strategy
por: Sattar, Yasar, et al.
Publicado: (2021) -
Reply to “SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection”
por: Sattar, Yasar, et al.
Publicado: (2020) -
Brugada Pattern Type 2 Diagnosis Unmasked by Aspiration Pneumonia
por: Sattar, Yasar, et al.
Publicado: (2020) -
High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS
por: Hernández-Romero, Diana, et al.
Publicado: (2012) -
The Predictive Power of the 14–51 Ng/L High Sensitive Troponin T (hsTnT) Values for Predicting Cardiac Revascularization in a Clinical Setting
por: De Jongh, Frank W., et al.
Publicado: (2022)